×
About 2,038 results

ALLMedicine™ Dry Skin Center

Research & Reviews  366 results

Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
https://clinicaltrials.gov/ct2/show/NCT04841499

Nov 18th, 2021 - Protocol Outline Protocol Title: Effects of a seven-day BASIS™ supplementation on menopausal syndromes and measurements of the urinary vitamin B3 and estradiol levels in pre-, peri- and post-menopause. I. Abstract Context: Nicotinamide adenine din...

A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
https://clinicaltrials.gov/ct2/show/NCT03434418

Nov 17th, 2021 - This is a research study to find out if a drug called, osimertinib, is safe and effective in treating advanced Non-Small Cell Lung Cancer (NSCLC) by targeting the treatment of epidermal growth factor receptor (EGFR) mutation exon 18 G719X, exon 20...

Lifetime prevalence and determinants of hand eczema in an adolescent population in Germ...
https://doi.org/10.1111/jdv.17814
Journal of the European Academy of Dermatology and Venere... Wang J, Tischer C et. al.

Nov 16th, 2021 - Hand eczema is a common inflammatory skin disorder in both adolescence and adulthood. We sought to assess the lifetime prevalence of hand eczema and associated exogenous and endogenous risk factors among adolescents in Germany. This was a cross-se...

Natural moisturizing factors in children with and without eczema: Associations with lif...
https://doi.org/10.1111/jdv.17787
Journal of the European Academy of Dermatology and Venere... Basu MN, Mortz CG et. al.

Nov 8th, 2021 - Filaggrin-derived natural moisturizing factors (NMF) play an important role in skin barrier function and in atopic dermatitis (AD). Its deficiency is associated with dry skin and increased surface pH. Studies on childhood environmental exposures a...

Optimal application method of a moisturizer on the basis of skin physiological functions.
https://doi.org/10.1111/jocd.14560
Journal of Cosmetic Dermatology; Ueda Y, Murakami Y et. al.

Nov 8th, 2021 - Clinical studies have clarified the usefulness of moisturizers for dry skin diseases. However, few reports exist on the appropriate application of moisturizers with respect to the skin physiological functions. To clarify the optimal moisturizer ap...

see more →

Guidelines  1 results

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibito...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532717
Drugs Califano R, Tariq N et. al.

Jul 19th, 2015 - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs have a prove...

see more →

Drugs  263 results see all →

Clinicaltrials.gov  22 results

Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
https://clinicaltrials.gov/ct2/show/NCT04841499

Nov 18th, 2021 - Protocol Outline Protocol Title: Effects of a seven-day BASIS™ supplementation on menopausal syndromes and measurements of the urinary vitamin B3 and estradiol levels in pre-, peri- and post-menopause. I. Abstract Context: Nicotinamide adenine din...

A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
https://clinicaltrials.gov/ct2/show/NCT03434418

Nov 17th, 2021 - This is a research study to find out if a drug called, osimertinib, is safe and effective in treating advanced Non-Small Cell Lung Cancer (NSCLC) by targeting the treatment of epidermal growth factor receptor (EGFR) mutation exon 18 G719X, exon 20...

The Effect of ESWT in Carpal Tunnel Syndrome
https://clinicaltrials.gov/ct2/show/NCT04896398

May 21st, 2021 - Carpal tunnel syndrome is a clinical picture that occurs with a group of symptoms and signs as a result of compression and compression in the carpal tunnel where the median nerve passes to the wrist. Another name is hand-wrist canal disease, the m...

A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil
https://clinicaltrials.gov/ct2/show/NCT04666675

Apr 8th, 2021 - Atopic Dermatitis (AD) is a chronic inflammatory skin disease that is characterized by intense itching, oozing and crusting, redness, skin erosion and dry skin. This study will evaluate how well upadacitinib compared to placebo (no medicine) works...

Determining Molecular Drivers of Radiation Dermatitis
https://clinicaltrials.gov/ct2/show/NCT04764682

Feb 21st, 2021 - This study is being conducted to address key gaps in current knowledge and set the stage for rational design of strategies to prevent (pre-exposure to radiation), mitigate (post-exposure to radiation before overt signs/symptoms appear), and/or tre...

see more →

News  138 results

FDA OKs First Drug for Most Common Form of Dwarfism
https://www.medpagetoday.com/endocrinology/growthdisorders/95786

Nov 19th, 2021 - The FDA granted accelerated approval to the first drug to spur growth in kids with the most common form of dwarfism, the agency announced on Friday. Vosoritide (Voxzogo), a once-daily injectable treatment, is indicated for children 5 years and old...

NSCLC: Mobocertinib for Patients With EGFR Exon 20 Insertion Mutations
https://www.onclive.com/view/nsclc-mobocertinib-for-patients-with-egfr-exon-20-insertion-mutations

Oct 27th, 2021 - Transcript: Erminia Massarelli, MD, MS, PhD: The mechanism of action of mobocertinib [Exkivity] is an irreversible EGFR tyrosine kinase inhibitor. However, it differs from osimertinib [Tagrisso], which is currently approved for exon 19 and21 muta...

Dr. Lacouture On Preventing Dermatological Adverse Events in Melanoma
https://www.onclive.com/view/dr-lacouture-on-preventing-dermatological-adverse-events-in-melanoma

Oct 6th, 2021 - Mario E. Lacouture, MD, a dermatologist with Memorial Sloan Kettering Cancer Center, explains how providers can manage adverse events that result from melanoma therapies. BRAF and MEK inhibitors have numerous common side effects that can some...

Partner Perspectives: Moving Cholangiocarcinoma Into the Age of Targeted Therapy
https://www.onclive.com/view/partner-perspectives-moving-cholangiocarcinoma-into-the-age-of-targeted-therapy

Oct 6th, 2021 - Biliary tract cancers are an aggressive group of malignancies that historically have been very challenging to treat because of their anatomical location and limited responsiveness to systemic therapy.1-3 Biliary cancers arise from the epithelial l...

Adagrasib Shows Impressive Activity in KRAS G12C–Mutant CRC
https://www.onclive.com/view/adagrasib-shows-impressive-activity-in-kras-g12c-mutant-crc

Sep 19th, 2021 - Adagrasib (MRTX849) alone or in combination with cetuximab (Erbitux) elicited encouraging antitumor activity and safety in heavily pretreated patients with KRAS G12C–mutant colorectal cancer (CRC), according to findings from the phase 1/2 KRYSTAL-...

see more →

Patient Education  25 results see all →